Treatment of osteoporosis with parathyroid hormone: evidence and perspective

Parathyroid hormone (PTH) is a promising bone formation-stimulating agent, and the recent large-scale randomized controlled trial (RCT) revealed that parathyroid hormone increases and reduces lumbar bone mineral density and fracture risk, respectively, more potently than bisphosphonates. Moreover, PTH is also effective for male or glucocorticoid-induced osteoporosis. However, the recent studies showed that the co administration of PTH and bisphosphonate is not good. The further accumulation of evidence about the combined or subsequent therapy is expected.     

Postirradiation malignant fibrous histiocytoma in a patient with squamous carcinoma of the uterine cervix--an autopsy case

An autopsy case of postirradiation sarcoma is described. The tumor, a malignant fibrous histiocytoma, occurred in the radiation fied 7 years after postoperative external beam radiation therapy (6000 rad) for squamous cell carcinoma of the cervix. To our knowledge, 11 cases of postirradiation malignant fibrous histiocytoma have been reported in the literature and only one occurrence of this neoplasm after treatment for cervical cancer has been described. We review the literature on postirradiation sarcoma with special attention to malignant fibrous histiocytoma.     

Little effects of low dosage of levomepromazine on plasma risperidone levels

In the present study, we investigated the effects of levomepromazine on plasma risperidone concentrations in a steady state. Twenty patients taking risperidone at a stable dose for more than 2 weeks who were considered to require levomepromazine coadministration were selected. The scores of excitement in BPRS significantly decreased 2 weeks after the coadministration of levomepromazine. Plasma risperidone concentrations and the ratio of risperidone and 9-hydroxyrisperidone (risperidone/9-hydroxyrisperidone) did not change between before and 2 weeks after the coadministration of levomepromazine. The extrapyramidal symptoms were not worsened by the coadministration of levomepromazine. These results suggest that a low dosage of levomepromazine, use as a sedative adjuvant to risperidone treatment, have no statistically significant effect on the trough plasma concentrations of risperidone.     

Fetal ultrasonography to prevent irreversible neurological sequelae of neonatal neuroblastoma

An intra-abdominal mass was observed by fetal ultrasonography at 32 weeks of gestation. The baby was diagnosed as having neuroblastoma at the time of delivery at 39 weeks and its lower extremities were completely paralyzed. The chemotherapy after birth was quite effective to reduce the mass volume but neurological sequelae failed to improve. By carefully monitoring the movement of extremities, it may have been possible to prevent irreversible paralysis by inducing delivery before that state was reached.     

Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [<Superscript>11</Superscript>C]flumazenil brain PET

To simplify the acquisition protocol of carbon-11 labeled flumazenil (FMZ) positron emission tomography (PET) for distribution volume (DV) images, we attempted to obtain standardized uptake value (SUV) images compatible with DV images, and assessed the applicability of this method in patients with unilateral cerebrovascular diseases (CVD). [¹¹C]FMZ PET was performed in ten normal subjects. A DV image and ten sequential 5-min SUV images were generated for each subject. We investigated the correlation coefficient (r) and standard estimation of error (SEE) between the latter ten static images and the DV image using the pixel-by-pixel method, thereby determining the optimum acquisition phase. The same FMZ PET procedure was performed in 15 patients with unilateral CVD. Twenty regions of interest (ROIs) were positioned both in lesioned areas and in symmetrical regions. DV and SUV in the optimum phase for each ROI were calculated to compare the lesion-to-normal (L/N) ratio of DV and that of SUV. The highest r and a low SEE (r=0.957, SEE=633) were observed from 30 to 35 min after tracer administration in the study of normal subjects. A high r (0.945) and a low SEE (0.0438) between the DV L/N ratio and the SUV L/N ratio were obtained in the study of patients. Our study suggests that SUV images acquired from 30 to 35 min after FMZ administration are a suitable alternative to DV images not only in normal subjects but also in patients with unilateral CVD. This simple method seems to be valuable for the identification of altered neuronal activity in patients with CVD.     

Ovarian vessel dilatation with ovarian mass on MR images: influence of pelvic venous plexus dilatation

PURPOSE: We assessed the value of analyzing visualization of the ovarian vessels in relation to the features of ovarian masses using MR images. MATERIALS AND METHODS: 74 patients with 91 masses (61 benign lesions and 30 malignant lesions) were evaluated. Ovarian masses were classified using the following features: 1) benignancy, 2) characterization, and 3) maximum diameter. We assessed the relationship between visualization and the diameter of the ipsilateral ovarian vessels and the features of ovarian masses. In addition, we assessed the relationship between visualization and the diameter of ovarian vessels and pelvic venous plexus (PVP) dilatation. RESULTS: Regardless of tumor laterality, 82% of ovarian vessels were visualized (121/148 vessels) on MR images. There was a significant relationship between the average diameter of ovarian vessels and dilatation of PVP (p<0.001). In patients without dilatation, there was a stronger relationship between ovarian vessel average diameter and benignancy (p=0.007), and the character of ovarian mass (solid versus cystic; p<0.05, mixed versus cystic; p<0.01). CONCLUSION: We confirmed a strong relationship between the diameter of ovarian vessels and dilatation of PVP. If ovarian vessels are dilated in patients without dilatation of PVP, we could suggest the possibility of malignant ovarian tumor.     

Lung adenocarcinoma presenting with enlarged and multiloculated cystic lesions over 2 years

We report a case of lung adenocarcinoma in which cystic lesions enlarged and multiloculated over 2 years. Histological examination of the resected specimen found proliferation of nonmucinous adenocarcinoma cells along the alveolar walls, revealing bronchioloalveolar cell carcinoma type extension. In cystic lesions, particularly those not associated with inflammation, lung adenocarcinoma, particularly bronchioloalveolar cell carcinoma type, should be a diagnostic consideration. .